RSV Prevention: Putting the Science Into Practice
In Fall 2023, three new products became available to prevent RSV: a monoclonal antibody for infants and high-risk toddlers, a vaccine for pregnant women, and…
Course Instructor: Lori Handy, MD, MSCE
Nirsevimab (Beyfortus)
For the first time, a preventative medicine is available to protect infants and high-risk toddlers from respiratory syncytial virus (RSV). Lori Handy, MD, MSCE, attending…